Advertisement

Topics

Sanofi Pasteur and March of Dimes Company Profile

17:09 EDT 28th June 2017 | BioPortfolio

March of Dimes is the leading organization for pregnancy and baby health. With chapters nationwide and through its premier event, March for Babies, March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit www.marchofdimes.com or www.nacersano.org.


News Articles [1154 Associated News Articles listed on BioPortfolio]

Sanofi Pasteur inks antibody discovery accord for influenza vaccine research

Sanofi Pasteur, the vaccines business of French pharma major Sanofi, has entered into a collaborative…

Sanofi Pasteur to pay $19.9 million for overcharging the US VA

Sanofi Pasteur has agreed to pay $19,868,194 to resolve claims that it incorrectly calculated drug prices…

Sanofi Pasteur & AstraZeneca Join To Develop, Commercialize MEDI8897

LONDON (dpa-AFX) - Sanofi and its vaccines unit Sanofi Pasteur announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to develop and commercialize...

Sanofi Pasteur, MedImmune Partner on Phase II-Stage mAb against RSV in Infants

Sanofi Pasteur and MedImmune agreed a potentially €615 million (approximately $647 million) collaboration to develop the latter’s Phase II-stage monoclonal antibody (mAb) MED18897, for the passive...

Synagis maker MedImmune teams with Sanofi Pasteur on mAb RSV drug

Sanofi Pasteur and MedImmune have partnered to develop a monoclonal antibody (mAb) based treatment for respiratory syncytial virus.

Sanofi-Pasteur Agrees To Pay $19.9 Mln Fine For Drug Overcharges

PARIS (dpa-AFX) - Sanofi-Pasteur has agreed to pay $19.87 million to resolve claims that it incorrectly calculated drug prices and thereby overcharged the U.S. Department of Veterans Affairs or VA...

MedImmune and Sanofi Pasteur in LRTI Drug Pact

AstraZeneca’s biologics R&D arm MedImmune and Sanofi’s vaccines division Sanofi Pasteur have agreed to develop and jointly commercialize the monoclonal antibody MEDI8897 for the treatm...

Messenger RNA a ‘game-changer’ for vaccine industry, Sanofi Pasteur

Sanofi Pasteur says heavy investment in messenger RNA (mRNA) is warranted as such technology could revolutionise vaccine development and manufacturing.

Drugs and Medications [59 Associated Drugs and Medications listed on BioPortfolio]

Citranatal [Mission Pharmacal Company]

CitraNatalB-CalmRx Prenatal Vitamin with two 25 mg each Vitamin B tablets

Citranatal harmony [MISSION PHARMACAL COMPANY]

CitraNatal Harmony Rx Prenatal Vitamin Gel Cap

Citranatal assure [Mission Pharmacal Company]

CitraNatalAssure Rx Prenatal Vitamin Tablet and 300 mg DHA Capsule

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Hiprex(methenamine hippurate tablets usp) [sanofi-aventis U.S. LLC]

HIPREX(methenamine hippurate tablets USP)

PubMed Articles [199 Associated PubMed Articles listed on BioPortfolio]

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the...

The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.

With approximately 3 billion people at risk of acquiring the infection, dengue fever is now considered the most important mosquito-borne viral disease in the world, with 390 million dengue infections ...

Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015.

 A unit of the European Mobile Laboratory (EMLab) consortium was deployed to the Ebola virus disease (EVD) treatment unit in Guéckédou, Guinea, from March 2014 through March 2015.

Thomas Earl Starzl, MD, PhD Transplant Pioneer, Polymath, Mentor March 11th, 1926-March 4th, 2017.

G-protein based ELISA as a potency test for rabies vaccines.

The NIH test is currently used to assess the potency of rabies vaccine, a key criterion for vaccine release. This test is based on mice immunization followed by intracerebral viral challenge. As part ...

Clinical Trials [180 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on v...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with ...

Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine

Phase III, open, mono-center study in 177 infants who received a dose of Hep B vaccine at birth or within 1 month after birth. Infants will receive Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T c...

Companies [290 Associated Companies listed on BioPortfolio]

Sanofi Pasteur and March of Dimes

March of Dimes is the leading organization for pregnancy and baby health. With chapters nationwide and through its premier event, March for Babies, March of Dimes works to improve the health of babies...

March of Dimes and Sanofi Pasteur

March of Dimes and Sanofi Pasteur Inc.

sanofi pasteur and The March of Dimes

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

More Information about "Sanofi Pasteur and March of Dimes" on BioPortfolio

We have published hundreds of Sanofi Pasteur and March of Dimes news stories on BioPortfolio along with dozens of Sanofi Pasteur and March of Dimes Clinical Trials and PubMed Articles about Sanofi Pasteur and March of Dimes for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi Pasteur and March of Dimes Companies in our database. You can also find out about relevant Sanofi Pasteur and March of Dimes Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record